Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2025 ,inter alia, to consider and approve the unaudited financial (Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.9 pts more than Nifty Microcap 250 and 1.1 pts more than its Other Agricultural Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Indrayani Biotech has rescheduled its Board meeting to December 11, 2025, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. The earlier board meeting (dated November 14, 2025) was postponed because the Audit Committee asked for additional information and clarifications. The Board will also take note of the resignation of Ms. Lakshmiprabha Kasiraman (DIN: 02885912) from her position as Director. The trading window for insiders remains closed from October 1, 2025, until 48 hours after the results are announced.
Shareholders should watch the December 11 meeting closely — the prior postponement at the Audit Committee's request may hint at last-minute adjustments or concerns in the numbers. A single director resignation is generally routine, but the delay in financial reporting could create near-term uncertainty for the stock.